Audrey Papp is a Research Specialist and Technical Director of the Pharmacogenomics Core Laboratory at the Ohio State University College of Medicine Center for Pharmacogenomics. As technical director, Audrey played a leading role in implementation of Next Generation Sequencing in the Pharmacogenomics (PGx) Core Laboratory. The PGx Core Lab is currently using Ion Torrent PGM, and Ion Proton deep sequencing platforms. Under Audrey's guidance, the OSU Pharmacogenomics Core Lab was designated as an Ion Torrent Certified Service Provider, recognized for proficiency in Exome, RNA transcriptome and AmpliSeq transcriptome sequencing as well as other molecular techniques. Audrey's expertise continues to be instrumental in developing new methods and approaches geared towards discovery of functional genetic biomarkers.

In her career, Audrey has been successful at design and implementation of new concepts and programs in both research and clinical areas. Previously, as supervisor of the Clinical Molecular Pathology Laboratory in the Department of Pathology at The Ohio State University Medical Center, she played a key role in developing the test portfolio, and establishing the Molecular Pathology Laboratory as a CLIA certified lab. In addition to participation in both clinical and research aspects of health care, she is a contributing author on over 80 papers. Audrey has been a featured speaker, and workshop leader at national conferences, webcasts and other events. One of her most recent projects was to create a new OSU graduate course: Personalized Therapeutics and Pharmacogenomics, a 3 credit online class in the new OSU Master's Program in Translational Pharmacology. Audrey is currently working on a pilot project with the Bill and Melinda Gates Foundation to develop better tuberculosis vaccines using targeted transcriptome sequencing and functional genetic variant analysis.